Mastomys coucha, an African rodent, is a useful animal model of papillomavirus infection, as it develops both premalignant and malignant skin tumors as a consequence of a persistent infection with Mastomys natalensis papillomavirus (MnPV). In this study, we mapped the MnPV transcriptome in productive lesions by both classical molecular techniques and high-throughput RNA sequencing. Combination of these methods revealed a complex and comprehensive transcription map, with novel splicing events not described in other papillomaviruses. Furthermore, these splicing occurrences could potentially lead to the expression of novel E2, E1^E4, E7 and L2 isoforms. Expression level estimation of each transcript showed that lateregion mRNAs considerably outnumber early transcripts, with species coding for L1 and E1^E4 being the most abundant. In summary, the full transcription map assembled in this study will allow us to further understand MnPV gene expression and the mechanisms that lead to natural tumour development.
INTRODUCTION
Papillomaviruses (PVs) are epitheliotropic viruses with a circular, double-stranded genome of around 8 kb. There are currently more than 300 PVs sequenced and almost one third belong to animal species (Van Doorslaer et al., 2013) . All these PVs are classified in different genera according to sequence similarities within the L1 ORF. Human PVs (HPVs) can be found in five different genera (Bzhalava et al., 2015) , and most of the knowledge on the contribution of PVs to pathogenesis derives mainly from studies with aHPVs, which infect mucosal sites. However, the vast majority of HPVs known are the cutaneous types distributed throughout all the genera, with several types from the alpha, gamma and mu genera associated with the development of skin warts and some beta types linked to the development of non-melanoma skin cancer (Cardoso & Calonje, 2011) . In fact, recent metagenomic analyses of the human virome show that the highest prevalence of HPV is found in the skin (61 %), followed by the vagina (41.5 %), mouth (30 %) and gut (17.3 %) (Ma et al., 2014) . Another study revealed that even more than 95 % of all viral sequences detected in skin samples belong to the papillomavirus family, mostly to the b-and g-genera. Here also, co-infections can be discerned, which allows speculation about potential inclusion/ exclusion mechanisms between different HPV types in the same cell that may modulate the immune response and, in turn, viral persistence (Bzhalava et al., 2014) .
PV infection is thought to be transmitted by close contact, by which the infective particles reach the keratinocytes in the basal layer of the squamous epithelium through wounded tissue. Following infection, viral DNA is replicated and gene expression starts, which is tightly controlled by keratinocyte differentiation (Johansson & Schwartz, 2013) . Productive infections result in benign hyperproliferative lesions in which high levels of viral transcription, genome amplification and virion assembly take place (Chow & Broker, 2007) . However, the exact mechanism of how these processes are linked to tissue differentiation and viral splicing and how this affects papillomavirus malignancy is not fully understood. Papillomavirus gene expression is a complex process which involves a switch in the usage of two or more viral promoters and extensive alternative RNA splicing and polyadenylation. This results in very complex transcription maps for all of the PVs studied to date (Baker & Calef, 1997; Johansson & Schwartz, 2013) . These transcripts usually feature suboptimal splicing signals, contain multiple introns and exons, are bicistronic or polycistronic and overlap with each other (Jia et al., 2009) . As a rule, there is more than one transcript potentially coding for the same ORF but with different transcription start and termination sites, which makes the analysis difficult.
Although valuable research on HPV biology has emerged from in vitro systems or even human samples, a comprehensive understanding of disease progression has been hampered by the lack of appropriate animal models of HPV infection, since papillomavirus species-specificity prevents HPVs from infecting non-human species (Doorbar, 2016) . Nevertheless, there are some animal PVs causing diseases in animal models that resemble the human situation. One of these models is the multi-mammate rodent Mastomys coucha. These animals are persistently infected with two different PVs, Mastomys natalensis papillomavirus (MnPV) and McPV2 (Nafz et al., 2008) , and spontaneously develop epithelial tumours as they age. The skin tumours, which are aetiologically linked to MnPV, are papillomas and keratoacanthomas, but also with lower-incidence squamous cell carcinomas (Vinzón et al., 2014) . Moreover, they also develop oral and genital lesions such as tongue papillomas and condylomas, respectively (Sch€ afer et al., 2011) . Infection with the skin-type MnPV occurs naturally early in the lifetime of the animals, which resembles the situation with most cutaneous HPVs. In a previous study, it was shown that M. coucha is an excellent model to test vaccination strategies against cutaneous papillomavirus infections under natural conditions (Vinzón et al., 2014; Vinzón & Rösl, 2015) . Furthermore, as MnPV infection mimics several aspects of cutaneous HPV-associated disease in humans, studies in this rodent could provide insights as to how lesions form and progress in naturally infected immunocompetent animals, also under the influence of co-factors such as immunosuppressants and UV irradiation. Therefore, a deeper knowledge of transcription regulation and the function of each individual transcript could contribute to a better understanding of the factors that lead to tumour progression. In order to gain insight into MnPV gene regulation in vivo, it is necessary to have a comprehensive map of viral transcripts and splicing isoforms. In this study, we defined the full MnPV transcriptome by a combination of RACE and RNA sequencing (RNA-seq) techniques. We found transcripts analogous to species found in other PVs, as well as novel RNAs that could potentially code for new ORFs.
RESULTS
Characterization of the RNA source RNA was extracted from productive lesions naturally raised in a MnPV-infected colony of M. coucha. All lesions were benign epithelial tumours classified as kerathoacanthomas (Fig. 1a, b ). Viral load in the tumours ranged from 1.6Â10 4 to 5.6Â10 5 copies per cell (n=4, mean=2.1Â10
5
). The physical status of the viral DNA in the tumours was assessed by Southern blotting (Fig. 1c) , which showed that MnPV is present in an episomal form. Furthermore, RNA-seq reads aligned both to the rodent and viral genomes failed to detect viral-cellular fusion transcripts, thus confirming the lack of integration of MnPV in most of the infected cells.
Mapping of MnPV early and late transcription start sites (TSSs)
For the mapping of the early and late TSSs, 5¢ RACE analyses were performed by using a protocol that targets capped mRNA, which ensures that only full-length transcripts are targeted. For the detection of the early TSS, a virus-specific antisense primer, R413, which binds to the E6 ORF, was used (Table 1) . As shown in Fig. 2(a) , a single 5¢ RACE product could be visualized by agarose gel electrophoresis. Because in other PVs there is some heterogeneity in the TSSs (Wang et al., 2011) , 25 clones of each RACE product were sequenced to identify the dominant TSSs. We found that all the early transcripts started from nt 78 within the upstream regulatory region (URR), with no alternative TSSs. The TSS starts with a guanine residue, which is in agreement with the conserved transcription start with a purine reported for eukaryotes (Butler & Kadonaga, 2002) . Additionally, a TATA box motif is present at nt 52, 25 bp upstream of the TSS, which reinforces the authenticity of the promoter.
For the mapping of the late TSS, a virus-specific antisense primer, R3452, was designed to anneal within the E4 ORF. This strategy was used because in most of the previously known PV transcriptomes the most abundant transcript is the one coding for an E1^E4 protein, which can be originated from either an early TSS located in the URR or a late TSS located in the E7 ORF (Nasseri et al., 1987) . Because of the considerable intron spliced in such transcripts, a primer located in the E4 ORF would be conveniently close to the late TSS, being optimal for amplification by 5¢ RACE. As in the case of the early promoter, a single 5¢ RACE product could be detected that was located at nt 710 (Fig. 2) . Sequencing of 25 clones showed no different TSS. Similar to the early TSS, this TSS also starts with a purine residue, in this case an adenine. In silico promoter analysis revealed the presence of a more weakly conserved conserved TATA box (Bucher, 1990) at position nt 680, 30 bp upstream of the TSS.
Mapping of MnPV early and late polyadenylation cleavage sites (CSs)
The MnPV early CS was previously predicted to be located at the beginning of the L2 ORF at nt 4350. By contrast, the late CS was predicted to be at nt 7298, which is the first polyadenylation signal (pAS) after the L1 ORF (Tan et al., 1994) . To determine the early CS (pAE), we conducted a 3¢ RACE with the MnPV-specific sense primer F3307 (Table 1) , located within the E2 ORF. This is a very important regulatory region that controls late gene expression by blocking expression of L1 and L2 during the early stages of the viral life cycle (Johansson & Schwartz, 2013) . Analysis of the 3¢ RACE product showed a single 1000 bp band by electrophoresis, and analysis of 12 different clones showed that pAE is located at nt 4370 or 4376 (Fig. 3) , 17-23 nt downstream of the AAUAAA signal. Both CSs were used at roughly the same frequency, with 6/12 clones displaying each CS. To detect the late CS (pAL), we designed a 3¢ RACE with the MnPV-specific sense primer F6097 The analysis of the sequences downstream of the cleavage site showed in both cases the highly conserved U/GU-rich motif, which is required for the cleavage stimulation factor in RNA polyadenylation (Zhao et al., 1999) . The identification of those cis elements, which are required for every efficient RNA polyadenylation, validated the cleavage sites detected.
Mapping of MnPV splice junctions
Different strategies were pursued in order to elucidate MnPV transcripts. First, to get a comprehensive list of MnPV splice junctions (SJs) regardless of their abundance, we performed RNA-seq of a keratoacanthoma, which is a very sensitive technique that can detect even rare splicing events. Reads were aligned to the MnPV genome and results showed that 3 974 913 reads (1.45 % of total reads) derived from viral transcripts. SJs were detected with Tophat2 (Kim et al., 2013) and only junctions with at least 100 reads were taken into account for the analysis. With this strategy, a total of 26 splicing junctions could be detected ( Table 2) .
Validation of the junctions found by RNA-seq and assembly of transcripts was achieved by additional 5¢ RACE experiments and reverse transcription (RT)-PCR with primers spanning the splice junctions (Table 1) . In order to achieve specificity to the spliced transcript and not to anneal to the unspliced variant, sense primers were designed so that their 3¢ end contained two or three nucleotides from the 5¢ end of the second exon, with at least two mismatches to the 5¢ end of the intron, one of which was necessarily the 3¢ clamp.
In the same way, anti-sense primers were designed with their 3¢ end annealing two or three residues of the 3¢ end of the first exon. RACE and PCR products were sequenced, confirming the specificity of the annealing and showing the particular combination of exons in each transcript. With this approach, 13 of the 26 splicing junctions found by RNA-seq could be validated. Additionally, we found new SJs in these samples (808^1245, 2496^3698, 4903^6733) that were not detected in the RNA-seq data of the original sample. Analysis of these junctions showed that most of them contain classical introns with the consensus 5¢ GU dinucleotide at their 5¢, the AG dinucleotide at their 3¢ and the quite conserved AG dinucleotide at the 3¢ end of exons (Table 2; Zheng, 2004) . These 13 SJs could be mapped to 23 different transcripts, both early and late (Fig. 4 , Table 3 ).
We used our transcript annotation as an input in the software CEM (Li & Jiang, 2012) to estimate the transcript expression levels in the RNA-seq data (Table 3) . Analysis revealed that late transcripts are the most abundant in the keratoacanthoma (341 307 fragments per kilobase of transcript per million mapped reads, FPKM), early transcripts are the least abundant (20 720 FPKM) and transcripts which start in the late differentiation-dependent promoter but end in the early pA CS come in the middle (45 546 FPKM). The abundance of the late transcripts can also be evidenced by the clearly high amount of MnPV reads which align to the late region (Fig. 5 ).
Analysis of MnPV transcriptome in productive lesions
We performed a prediction of the potential ORFs coded by each of the transcripts detected (Table 3) . Besides the prediction of transcripts coding for proteins already shown for other PVs (E1, E2, E6, E7, L1, L2, E1^E4, E8^E1C, E8^E2C), we found potentially novel ORFs not previously described. Transcript B codes for a potential E2 variant, named E2*I, lacking the transactivation domain whereas transcript C codes for a similar variant, E2*II, which additionally lacks a segment of the hinge domain (Figs S1 and S2, available in the online Supplementary Material). We also found E1^E4 variants, namely E1^E4*I and E1^E4*II, which lack 48 and 38 residues from the 266 aa of the fulllength E1^E4, respectively (Fig. S3 ). These variants are encoded by several early and late transcripts (E, F, N, R, S, T, U, V), some of them being very abundant (Table 3) , and arise from the novel and frequent splicing junctions 3307^3452 and 3337^3452 (Table 2) , both of which do not change the reading frame.
Also in the early region, we could predict a novel truncated form of the E7 protein, named E7DC. This protein would lack the complete zinc-binding C-terminal domain of the full-length E7 (Fig. S4) . Such a variant has not yet been described in other PVs to our knowledge.
In the case of the ORFs exclusive for the late region, we found a new putative L2 isoform, L2*, which is less than half the size of the full-length L2, lacking 306 of the 521 residues (Fig. S5) , mostly due to the loss of the C-terminal region (with exception of the 6 C-terminus amino acids).
DISCUSSION
In this study we showed that MnPV, similarly to other PVs, uses at least two promoters for viral gene expression. Analysis of the MnPV TSSs revealed that the viral early promoter is located upstream of the E6 gene, at nt 78. This early promoter contains a TATA box 23 bp upstream of the TSS, in accordance with other early TSSs found upstream of E6 in other PVs like HPV18 P102 (Wang et al., 2011) , HPV16 P97 (Grassmann et al., 1996) , HPV5 P191 (Sankovski et al., 2014) , HPV8 P175 (Stubenrauch et al., 1992) and HPV31 P99 (Hummel et al., 1992) . This early TSS is very homogeneous, with all transcripts beginning at exactly the same nucleotide. This is in contrast to data from other extensively studied PVs, like HPV18 (Wang et al., 2011) and HPV16 (Grassmann et al., 1996) , for which a heterogeneous early TSS was found, differing in a few nucleotides from the main TSS. Sankovski et al. (2014) , who recently published the HPV5 transcriptome, also found a homogeneous early TSS, SJs are identified by their splicing donor/acceptor position. The number of reads aligning to each junction as determined by Tophat2 is displayed in the column 'Reads'. Thirteen of these SJs were validated by RACE or conventional PCR followed by Sanger sequencing. All the validated SJs show conventional introns with a GT dinucleotide at the 5¢ end and an AG dinucleotide at the 3¢ end. Non-consensus splicing donors/acceptors (1201^5652, 1730^3697 and 3872^4151) only appeared in reads detected by RNA-seq but were not validated.
and suggested that the differences in heterogeneities with the alpha PVs could be due to a different transcriptional environment of cutaneous versus mucosal HPVs. Although this would be a possible explanation, HPV8, for instance, which has the same tropism and is a closely related species to HPV5, also showed heterogeneity in the exact position of the early TSS (Stubenrauch et al., 1992) . We propose an alternative explanation for the differences found between the early TSSs from HPV5 and MnPV and those from the rest of the PVs studied, based on the method used for their detection. Both Sankovski et al. (2014) and our study used the 'First Choice RLM-RACE Kit', which is designed to amplify cDNA only from capped mRNA, usually producing a homogeneous product after PCR. As a matter of fact, Similar transcripts were found in several PVs in the published database for papillomavirus transcript maps (Baker & Calef, 1997) , and also in particular in HPV5 (Sankovski et al., 2014) , HPV11 (Chiang et al., 1991) , HPV 16 (Sherman & Alloul, 1992; Milligan et al., 2007; Chen et al., 2014) and HPV18 (Wang et al., 2011) . †FPKM, fragments per kilobase of transcript per million mapped reads. ‡In HPV5/18 with a different TSS.
given that P78 is associated with a TATA-box, it would be favoured that transcription initiation occurs exactly at one position (Narlikar, 2014) . In particular cases, e.g. for the HPV16 early TSS, the different starting nucleotides might reflect the real situation as a result of the presence of different TATA boxes in close proximity, leading to different initiations of transcription (Grassmann et al., 1996) .
Additionally, a strong promoter was identified within the E7 ORF, with a transcription starting site at nt 710. Following gel purification and cloning, we randomly sequenced 25 clones, which surprisingly showed the same initiation site at position 710, in contrast to other PVs that have a heterogeneous TSS. Examination of the region immediately upstream of P710 revealed a TATA-like sequence 30 nt upstream of the TSS. This element does not conform to the canonical TATA box but is located in a favoured position; experimental confirmation that this element is functional is needed. A late differentiation-dependent promoter, generally located within the E7 ORF, is also found in other PVs such as HPV5, HPV11, HPV16, HPV18 and HPV31 (Hummel et al., 1992; Stubenrauch et al., 1992; Grassmann et al., 1996; Wang et al., 2011; Sankovski et al., 2014; IsokPaas et al., 2015) . Generally these are TATA-less promoters, although a putative TATA-box was found in the case of HPV5 P840, as in the case of our findings for MnPV. However, as stated above, all of these TSSs are heterogeneous, even when the RLM-RACE method was used for detection. Hence, we cannot exclude that sequencing of more clones would reveal some minor heterogeneity also in MnPV.
Several studies report the use of other promoters by PVs, such as intragenic promoters within the E6 and E1 ORFs. However, extensive 5¢ RACE studies with different primers did not reveal any such promoter in the samples we analysed (data not shown). A possible explanation for this is the origin of the sample, as it has been reported for other
PVs that more TSSs can be detected in raft cultures than in patient specimens, probably because a long-established lesion represents a less dynamic state (Chow & Broker, 2007) . In this context, further analysis of the MnPV transcriptome in Mastomys keratinocytes could allow the discovery of such promoters.
Polyadenylation of messenger RNAs is an important posttranscriptional process that affects both viral and cellular gene expression. It involves the cleavage of the nascent transcript and the addition of a poly(A) tail containing 150 to 200 adenosines at the RNA 3¢ end (Zheng & Baker, 2006) . Immature RNAs that do not contain a poly(A) tail are unstable and rapidly degraded in the cytoplasm (Houseley et al., 2006) . Polyadenylation is triggered by recognition of different RNA signals by the polyadenylation machinery. These include at least two cis elements: a cleavage site (CS) or polyadenylation signal (pAS) AAUAAA and a U/GU-rich motif 10-30 nt downstream (Zheng & Baker, 2006) . Here we detected both the early and late consensus polyadenylation cleavage sites. Viral early transcripts are polyadenylated either at nt 4370 or 4376, by using a pAS at nt 4353. Both CSs seem to be used with the same frequency. By contrast, late transcripts are exclusively polyadenylated at nt 7322 by using a pAS at nt 7301.
Construction of the MnPV transcriptome by a combination of classical molecular biology techniques and state-of-the-art high-throughput RNA-seq revealed a complex transcript map with novel species. Of the 26 SJs detected by RNA-seq in one productive lesion, we could confirm 13 SJs by PCR and Sanger sequencing in two other samples, but the remaining 13 junctions could not be found. Conversely, we found new SJs in these samples (808^1245, 2496^3698, 4903^6733) that were not detected by RNA-seq in the original sample. Given that RNA-seq proved to be a very sensitive method that detects even splicing events occuring at low frequency, these SJs likely represent cryptic splicing donor/acceptor sites that are secondarily activated in the presence of factors which repress the utilization of the dominant sites.
Analysis of MnPV transcripts after ORF prediction reveals that most of these are polycistronic, as reported for other PVs. It must be noted, however, that in spite of the ORF prediction, the exact profile of proteins produced by each PV mRNA can only be confirmed after translation experiments. Theoretically, though, the strength of the AUG of each gene in an mRNA dictates how efficiently it is translated, although because of the ribosome scanning mechanism a strong Kozak start codon at the first ORF can efficiently block translation of downstream ORFs (Johansson & Schwartz, 2013) . Therefore, alternative splicing of PV mRNAs is needed in order to yield at least one transcript in which that specific gene is first, or in which the gene is preceded by only weak Kozak start codons that allow for leaky scanning to occur.
RNA-seq data showed the presence of a constant level of reads from nt 1176 to 2466, revealing the presence of transcripts coding for a full-length E1. These corresponded to transcript P, which was actually quite abundant (>10 000 FPKM). Some PVs code for an E1C which functions as a transactivator of the LCR in HPV16 and is up-regulated in cervical carcinoma with respect to benign lesions (Schmitt et al., 2010) . We could also find a transcript coding for the E1 variant E8^E1C (transcript G), although it was much rarer than the full-length transcript (<1000 FPKM).
Several transcripts encode E2 variants. Full-length E2 could be translated from four different transcripts (A, G, O and P), although only transcript O would favour its expression over other ORFs. There is also an E8^E2C variant encoded in transcript H, which has been described for other PVs, although this is much less abundant than the transcript coding for the full-length E2 (1795 vs 16 532 FPKM). The E8^E2C fusion protein comprises a short (10 aa) fragment of the E8 ORF fused to the C-terminal DNA binding and dimerization domain of the E2 protein, and has been shown to regulate viral transcription and replication by counteracting E2 functions (McBride, 2013) . Additionally, other E2 antagonists have been found in other PVs, such as E2-TR in BPV1 (Choe et al., 1989; Baars et al., 2003) . In our case we also found a second ORF, E2*I, which conserves the hinge and DNA-binding domain but lacks the transactivation domain, which would most likely render this protein an E2 repressor. Additionally, further splicing between positions 3307 and 3452 would give rise to an E2*II variant lacking a portion of the hinge domain. However, it remains to be determined whether that new variant is significant or is just a by-product of the very frequent 3307^3452 splicing, since abundance of transcript C is very low and a deletion of such a portion of the hinge region does not seem to be crucial for the function of the antagonist. As a matter of fact, as the E4 ORF lies within the region coding for the E2 hinge, this splicing would be functional only when in frame with the E4 ORF. Nevertheless, further functional studies are warranted in order to prove this hypothesis.
The most highly expressed HPV protein during productive infection is the E1^E4 fusion protein, which consists of a few amino acids of E1 fused to E4 coding sequences (Lee & Laimins, 2007) . E4 is highly divergent between different PVs, with sizes between 9 kDa and 25 kDa, but all of them share a few characteristics such as the high frequency of prolines and the presence of a central hydrophilic region containing a stretch of acidic and basic residues (Doorbar, 2013) . The fact that the E4 ORF lacks an ATG, together with the divergence in this gene, makes prediction of the ORF from the genomic sequence difficult. When the MnPV genome was first described, it was suggested that the E4 ORF comprised the region from nt 3169 to nt 3771 (Tan et al., 1994) . However, transcriptome analysis evidenced that the actual ORF lies between nts 3114 and 3926 and that the E1^E4 product arises as a consequence of the most abundant splicing between a strong splicing donor at position 808 and a strong splicing acceptor at position 3145. This product is encoded by several transcripts (D, M, Q), and constitutes the first ORF in two of these very abundant transcripts (M and Q), suggesting that it is a highly expressed product. In addition to the conventional E1^E4 ORF, we found two further splicing variants, E1^E4*I and E1^E4*II, which lack 48 and 38 residues from the 266 aa of the full-length E1^E4, respectively. Since the function of the different regions of the E4 protein is so poorly understood (Doorbar, 2013) , it is hard to speculate on the expected functions of these two new E1^E4 fusion proteins. Functional assays are needed in order to shed light on this matter.
Regarding the E6 and E7 oncogenes, we were not able to find E6 variants in productive lesions. However, these variants were only found in high-risk mucosal HPV types (Chow & Broker, 2007) , so their absence here is not surprising. Interestingly, though, we found a truncated E7 variant. The only previous E7 isoform described to our knowledge is an E6^E7 fusion which conserves the C-terminus of E7 (Ajiro & Zheng, 2015) . On the contrary, the E7DC potentially encoded in transcripts J and K is a truncation variant which lacks the zincbinding terminal domain and could therefore render it biologically inactive. Further studies will be performed to elucidate the functionality of this novel E7 isoform.
The most abundant MnPV transcript in productive lesions is a monocistronic species coding for the major capsid protein L1. Besides transcript W, L1 should also be efficiently translated from the bicistronic transcript T, which additionally encodes E1^E4*I as its first ORF. Both transcripts have also been found in cutaneous HPVs and are related to the extensive production of virions in the tumours, whereas mucosal tumours derived from HPV6 or HPV11 infection are known to express only the bicistronic mRNA (Tomita & Simizu, 1993) . Additional polycistronic mRNAs potentially encoding L1 (Q, R, S, U, V) are unlikely to translate L1 efficiently, as translation of the ORF immediately upstream ends downstream of the L1 ORF. L2 was only present as the second ORF in polycistronic mRNAs, as is the case in other
PVs. However we could also find a novel transcript coding for a truncated L2 variant. Expression of species U was found to be quite abundant, but the properties that such a truncation would confer to the L2 protein are hard to predict as, in the case of the E4 variants, little is known about the structure of this protein (Wang & Roden, 2013) .
From the analysis of the MnPV and other PV trancriptomes, it becomes evident that PVs regulate expression of viral proteins in a coordinated manner that involves not only selective promoter usage, but also an intricate combination of alternative splicing events, which renders a very complex transcriptome from an 8 kb viral genome (Chow & Broker, 2007) . This mechanism allows the ribosomes to access different ORFs, thereby generating a diversity of proteins from a small genome. However, some of these alternatively spliced transcripts may simply reflect the absence of a mechanism to prevent promiscuous assortment of exons, and occurring at low frequency, they do not interfere with the production of the intended proteins or their functions (Chow & Broker, 2007) . As we can see, most mRNAs contain several ORFs, but whether they are truly polycistronic has to be yet demonstrated, as was done previously for only a few HPV mRNAs (Tomita & Simizu, 1993; Brown et al., 1996; Alloul & Sherman, 1999; Tang et al., 2006) .
In conclusion, our data show that MnPV expresses a complex transcriptome in productive lesions, including some novel species that potentially code for proteins never described for other PVs. We believe this comprehensive transcript map provides a solid basis for understanding MnPV pathogenesis, as well as a starting point for the study of novel PV proteins.
METHODS
Animals. Mastomys coucha from the DKFZ breeding colony were maintained under standard conditions (Vinzón et al., 2014) in compliance with German and European statutes, and all animal experiments were undertaken with the approval of the responsible Animal Ethics Committee (Regional Council of Karlsruhe, Germany; 35-918535-9185 .81/G-124/08).
Southern blot. DNA was extracted as described elsewhere (Vinzón et al., 2014) . Southern blotting was performed by standard methods (Sambrook et al., 1989) . DNA (2.5-5.0 µg) was digested overnight with either Apal, Xbal or Xhol (Thermo Fisher Scientific), known to have no recognition site, one or two sites in the MnPV genome, respectively. Membranes were hybridized with a unit-length MnPV-specific probe (Amtmann et al., 1984) .
Histological and immunohistochemical analysis. Tissue sections were fixed in 4 % buffered formaldehyde, embedded in paraffin, cut at 3 µm and stained by haematoxylin eosin or used for immunostaining as previously described (Vinzón et al., 2014) .
Preparation of RNA. RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. Additional treatment with the TURBO DNA-free Kit (Ambion) was performed to eliminate all traces of viral DNA. RNA integrity was assessed either by determination of the RIN (RNA integrity number) by an Agilent Bioanalyzer (for RNA-seq) or by visualization of sharp 28S and 18S rRNA bands on a 1 % agarose gel.
RACE. The 3¢ RACE was carried out to determine the early and late polyadenylation sites of the MnPV genome using the 5¢/3¢ RACE Kit, 2nd Generation (Roche) according to the manufacturer's protocol. After a reversed transcription of the MnPV RNA with a primer complementary to the natural poly(A) tail and degradation of the mRNA by the RNase H activity of the reverse transcriptase, the first-strand cDNA was amplified by PCR. A gene-specific primer and a PCR anchor primer were used. The PCR was carried out using Platinum Taqpolymerase (Invitrogen) with the following parameters: 95 C for 4 min, 30 cycles of 30 s at 95 C, 30 s at 60 C, 3 min at 72 C, and a final extension at 72 C for 10 min. The gene-specific primers F3303 and F6094 were designed to detect the early and late polyadenylation signals, respectively. Each PCR product was gel purified, cloned and sequenced.
The 5¢ RACE assays were performed using the First Choice RLM RACE Kit according to the manufacturer's protocol. This kit only detects a fulllength 5¢ capped mRNA because the RNA is pretreated with calf intestine alkaline phosphatase (CIP) that removes free 5¢ phosphates from other species, such as ribosomal RNA or fragmented RNA, which ensures that only full-length mRNA is amplified. Subsequently the RNA was treated with tobacco acid pyrophosphatase (TAP), which removes the cap structure and makes the RNA accessible for the ligation of a specific 45 base RNA adaptor. After the adapter ligation, a reverse transcription with random primers was performed and then a nested PCR was carried out using primers annealing to the adaptor and the sequence of interest. PCR was performed using Platinum Taqpolymerase (Invitrogen) with the following parameters: 95 C for 3 min, 35 cycles of 30 s at 95 C, 30 s at 60 C, 30 s at 72 C, and a final extension at 72 C for 7 min. Successful detection of the early and late promoters was performed using the following primers: R286 and R413 (early TSS); R3217 and R3452 (late TSS).
RNA-seq and data analysis. After RNA extraction, the purified RNA was sequenced on the Illumina HiSeq 2000 Sequencing platform in the DKFZ Genomics and Proteomics Core Facility. Briefly, the RNA was transcribed into a cDNA library which was cleaved into fragments of a size of 200-500 bp. Subsequently, specific adaptors were ligated to each cDNA fragment and the library was sequenced on the HiSeq 2000 with 100 bp paired-end settings. Adapter sequences were removed with cutadapt (Martin, 2011) before the reads were aligned against MnPV genome using Tophat2 (Kim et al., 2013) with -G option. To obtain transcript isoform expression levels, the alignment output from Tophat2 and a custom-curated MnPV transcript annotation were input to CEM (Li & Jiang, 2012) with -forceref parameter.
RT and PCR. RT was performed with the SuperScript II kit (Invitrogen). One to five µg of total RNA was incubated with 200 ng random primers and 0.5 mM dNTPs and denatured at 65 C for 5 min. The RT reaction was carried out by adding 5Â first-strand buffer, 10 mM DTT, 200 U SuperScript RT enzyme and the RNase inhibitor RNase-OUT (Invitrogen) and incubating at 42 C for 50 min, followed by a final heating to 70 C for 15 min to inactivate the enzyme. Amplification of reverse-transcribed cDNA was performed by PCR using the Platinum Taq Polymerase kit (Invitrogen) or the Pfu Polymerase kit (Thermo Scientific) according to the manufacturer's protocols. The PCR protocol for all amplifications was based on a primary denaturation step at 94 C for 5 min, followed by 25 cycles of 30 s at 94 C, 45 s at 60-65 C and 60 s at 72 C, with a final extension step of 10 min at 72 C.
Quantification of viral load. Quantification of MnPV DNA was performed with the iTaq Universal SYBR Green Supermix (BioRad) using 50 ng of total DNA per reaction, following the manufacturer's instructions as described elsewhere (Vinzón et al., 2014) .
Digestion, gel purification and ligation of DNA fragments. Analytical and preparative digestion of DNA was performed using bacterial type II restriction enzymes according to the conditions supplied by the manufacturer, whereby up to 1 and 10 µg DNA was applied in a total volume of up to 20 and 100 µl, respectively. DNA fragments were separated according to their size by agarose gel electrophoresis, stained by adding 1 µg ethidium bromide ml À1 to the fluid gel before the run and visualized by UV light (260 nm). As a size standard, GeneRuler 1 kb DNA ladder (Fermentas) was run on the same gel. The purification of DNA from agarose gels was performed with the QIAEX II Gel Extraction Kit (Qiagen) according to the manufacturer's protocol. DNA fragments were cloned into pGEM-T Easy (Promega) and sequenced using the GATC Biotech Sanger Service (GATC Biotech, Konstanz, Germany).
Prediction of coding potential. The coding potential of each mapped transcript was determined using the online software ORF finder (http://www.ncbi.nlm.nih.gov/projects/gorf). The predicted ORFs were matched to the described ORFs for PV genomes.
